|
1
|
Jemal A, Siegel R, Xu J and Ward E: Cancer
statistics, 2010. CA Cancer J Clin. 60:277–300. 2010. View Article : Google Scholar
|
|
2
|
Naora H and Montell DJ: Ovarian cancer
metastasis: integrating insights from disparate model organisms.
Nat Rev. 5:355–366. 2005. View
Article : Google Scholar : PubMed/NCBI
|
|
3
|
Molnar A and Georgopoulos K: The Ikaros
gene encodes a family of functionally diverse zinc finger
DNA-binding proteins. Mol Cell Biol. 14:8292–8303. 1994.PubMed/NCBI
|
|
4
|
Koipally J and Georgopoulos K: A molecular
dissection of the repression circuitry of Ikaros. J Biol Chem.
277:27697–27705. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Georgopoulos K, Bigby M, Wang JH, et al:
The Ikaros gene is required for the development of all lymphoid
lineages. Cell. 79:143–156. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Dumortier A, Kirstetter P, Kastner P and
Chan S: Ikaros regulates neutrophil differentiation. Blood.
101:2219–2226. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Wang JH, Nichogiannopoulou A, Wu L, et al:
Selective defects in the development of the fetal and adult
lymphoid system in mice with an Ikaros null mutation. Immunity.
5:537–549. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Payne KJ, Huang G, Sahakian E, et al:
Ikaros isoform x is selectively expressed in myeloid
differentiation. J Immunol. 170:3091–3098. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ezzat S, Mader R, Yu S, Ning T, Poussier P
and Asa SL: Ikaros integrates endocrine and immune system
development. J Clin Invest. 115:1021–1029. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Yang L, Luo Y and Wei J: Integrative
genomic analyses on Ikaros and its expression related to solid
cancer prognosis. Oncol Rep. 24:571–577. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
He LC, Xu HZ, Gu ZM, et al: Ikaros is
degraded by proteasome-dependent mechanism in the early phase of
apoptosis induction. Biochem Biophys Res Commun. 406:430–434. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhao KW, Li X, Zhao Q, et al: Protein
kinase Cdelta mediates retinoic acid and phorbol myristate
acetate-induced phospholipid scramblase 1 gene expression: its role
in leukemic cell differentiation. Blood. 104:3731–3738. 2004.
View Article : Google Scholar
|
|
13
|
Xavier LL, Viola GG, Ferraz AC, et al: A
simple and fast densitometric method for the analysis of tyrosine
hydroxylase immunoreactivity in the substantia nigra pars compacta
and in the ventral tegmental area. Brain Res Brain Res Protoc.
16:58–64. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Sherr CJ and Roberts JM: CDK inhibitors:
positive and negative regulators of G1-phase progression. Genes
Dev. 13:1501–1512. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Alt JR, Gladden AB and Diehl JA: p21(Cip1)
promotes cyclin D1 nuclear accumulation via direct inhibition of
nuclear export. J Biol Chem. 277:8517–8523. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Masamha CP and Benbrook DM: Cyclin D1
degradation is sufficient to induce G1 cell cycle arrest despite
constitutive expression of cyclin E2 in ovarian cancer cells.
Cancer Res. 69:6565–6572. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Ely S, Di Liberto M, Niesvizky R, et al:
Mutually exclusive cyclin-dependent kinase 4/cyclin D1 and
cyclin-dependent kinase 6/cyclin D2 pairing inactivates
retinoblastoma protein and promotes cell cycle dysregulation in
multiple myeloma. Cancer Res. 65:11345–11353. 2005. View Article : Google Scholar
|
|
18
|
Ezzat S and Asa SL: The emerging role of
the Ikaros stem cell factor in the neuroendocrine system. J Mol
Endocrinol. 41:45–51. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Yamamoto E, Ito T, Abe A, et al: Ikaros is
expressed in human extravillous trophoblasts and involved in their
migration and invasion. Mol Hum Reprod. 11:825–831. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Ezzat S, Yu S and Asa SL: Ikaros isoforms
in human pituitary tumors: distinct localization, histone
acetylation, and activation of the 5′ fibroblast growth factor
receptor-4 promoter. Am J Pathol. 163:1177–1184. 2003.PubMed/NCBI
|
|
21
|
Elliott J, Jolicoeur C, Ramamurthy V and
Cayouette M: Ikaros confers early temporal competence to mouse
retinal progenitor cells. Neuron. 60:26–39. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Alves CC, Carneiro F, Hoefler H and Becker
KF: Role of the epithelial-mesenchymal transition regulator Slug in
primary human cancers. Front Biosci. 14:3035–3050. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Kurrey NK, KA and Bapat SA: Snail and Slug
are major determinants of ovarian cancer invasiveness at the
transcription level. Gynecol Oncol. 97:155–165. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Catalano A, Rodilossi S, Rippo MR, Caprari
P and Procopio A: Induction of stem cell factor/c-Kit/slug signal
transduction in multidrug-resistant malignant mesothelioma cells. J
Biol Chem. 279:46706–46714. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Liotta LA, Abe S, Robey PG and Martin GR:
Preferential digestion of basement membrane collagen by an enzyme
derived from a metastatic murine tumor. Proc Natl Acad Sci USA.
76:2268–2272. 1979. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Batlle E, Sancho E, Franci C, et al: The
transcription factor snail is a repressor of E-cadherin gene
expression in epithelial tumour cells. Nat Cell Biol. 2:84–89.
2000. View
Article : Google Scholar : PubMed/NCBI
|
|
27
|
Nieto MA: The snail superfamily of
zinc-finger transcription factors. Nat Rev Mol Cell Biol.
3:155–166. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
28
|
Shih JY and Yang PC: The EMT regulator
slug and lung carcinogenesis. Carcinogenesis. 32:1299–1304. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Kenny HA and Lengyel E: MMP-2 functions as
an early response protein in ovarian cancer metastasis. Cell cycle.
8:683–688. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Akhurst RJ and Derynck R: TGF-beta
signaling in cancer - a double-edged sword. Trends Cell Biol.
11:S44–S51. 2001.PubMed/NCBI
|
|
31
|
Chou JL, Chen LY, Lai HC and Chan MW:
TGF-beta: friend or foe? The role of TGF-beta/SMAD signaling in
epigenetic silencing of ovarian cancer and its implication in
epigenetic therapy. Expert Opin Ther Targets. 14:1213–1223. 2010.
View Article : Google Scholar : PubMed/NCBI
|
